Archive

The Bundibugyo Ebola outbreak is accelerating in eastern DRC as deaths rise, urban cases emerge, borders tighten and testing capacity lags.

The GEMS solvency ratio is projected to fall below the legal 25% threshold, following the scheme’s capping of premium hikes.

South Africa’s Certificate Of Need Ruling has declared certain health provisions unconstitutional, ending a two-decade legal battle.

Explore the latest insights on the SA HIV Treatment Programme, revealing critical changes in treatment enrollment and funding.

Discover the implications of SA’s missing middle, where rising medical scheme costs leave many without adequate healthcare options.

GLP-1 Drugs In SA could spread as cheaper generics and oral pills arrive, changing food and alcohol demand and pushing premium health trends.

Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa’s local manufacturing goals.

South Africa’s Lenacapavir rollout begins on June 5, 2026, offering a new HIV prevention tool in high-burden districts.

Discover the benefits of the Africa Vaccine Procurement Framework for vaccine manufacturing and demand aggregation in Africa.

Biovac’s expansion funding in Africa hits $128m after a $20m French finance commitment, with the full $180m target due by the end of May.

German Drug Price Reforms aim to plug a €40bn health insurance gap by 2030, tightening rebates, reimbursements and hospital funding.